Japan Prices Kisunla Above Leqembi But May Cut In Future

Japan has granted an initial reimbursement price for Kisunla slightly above that for Alzheimer's rival Leqembi, but is holding out the prospect of future price revisions.

(Shutterstock)

More from Japan

More from Government Payers